A single molecular descriptor to predict solution behavior of therapeutic antibodies
-
- Jonathan S. Kingsbury
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Amandeep Saini
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Sarah Marie Auclair
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Li Fu
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Michaela M. Lantz
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Kevin T. Halloran
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Cesar Calero-Rubio
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Walter Schwenger
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Christian Y. Airiau
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Jifeng Zhang
- Biologics Development, Sanofi, Framingham, MA, USA.
-
- Yatin R. Gokarn
- Biologics Development, Sanofi, Framingham, MA, USA.
Description
<jats:p>Colloidal interactions in dilute solution singularly enable selection of well-behaved antibodies during drug discovery.</jats:p>
Journal
-
- Science Advances
-
Science Advances 6 (32), 2020-08-07
American Association for the Advancement of Science (AAAS)
- Tweet
Details 詳細情報について
-
- CRID
- 1360294648033527424
-
- ISSN
- 23752548
-
- Data Source
-
- Crossref